A study by Bjornevik et al. (Science, 2022) recently reported evidence of a causal link between previous EBV infection and the development of multiple sclerosis (MS), a demyelinating disease of the central nervous system. Viruses have previously been suggested as potential causative agents in several other autoimmune diseases, warranting a closer look at the immunology of antiviral responses.
The new PEPperCHIP® Epstein-Barr Virus Peptide Microarray contains the most immunogenic EBV antigens from the Immune Epitope Database converted into over 5,500 individual peptides. The microarray enables you to:
- Screen patient sera for EBV-specific antibody responses with amino acid resolution
- Investigate anti-EBV antibody fingerprints of MS patients vs. healthy controls
- Investigate autoantibody responses before and after COVID-19 vaccination
- Correlate IgG or IgA autoantibodies with disease progression
- Identify and characterize epitopes for EBV biomarker discovery, IVD, or vaccine development
|
